Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases

被引:179
作者
Malik, Hassan Z. [1 ]
Prasad, K. Rajendra [1 ]
Halazun, Karim J. [1 ]
Aldoori, Amir [1 ]
Al-Mukhtar, Ahmed [1 ]
Gomez, Dhanwant [1 ]
Lodge, J. Peter A. [1 ]
Toogood, Giles J. [1 ]
机构
[1] St James Univ Hosp, HPB & Transplant Unit, Leeds LS9 7TF, W Yorkshire, England
关键词
D O I
10.1097/SLA.0b013e318142d964
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Despite indications for resection of colorectal liver metastases having expanded, debate continues about identifying patients that may benefit from surgery. Methods: Clinicopathologic data from a total of 700 patients was gathered between January 1993 and January 2006 from a prospectively maintained dataset. Of these, 687 patients underwent resection for colorectal liver metastases. Results: The median age of patient was 64 years and 36.8% of patients had synchronous disease. The overall 5-year survival was 45%. The presence of an inflammatory response to tumor (IRT), defined by an elevated C-reactive protein (>10 mg/L) or a neutrophil/lymphocyte ratio of >5:1, was noted in 24.5% of cases. Only the number of metastases and the presence or absence of an IRT influenced both overall and disease-free survival on multivariable analysis. A preoperative prognostic score was derived: 0 = less than 8 metastases and absence of IRT; 1 = 8 or more metastases or IRT, and 2 = 8 or more metastases and IRT - from the results of the multivariable analysis. The 5-year survival of those scoring 0 was 49% compared with 34% for those scoring 1. None of the patients that scored 2 were alive at 5 years. Conclusion: The preoperative prognostic score is a simple and effective system allowing preoperative stratification.
引用
收藏
页码:806 / 814
页数:9
相关论文
共 65 条
  • [1] Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
  • [2] Tumor progression while on chemotherapy - A contraindication to liver resection for multiple colorectal metastases?
    Adam, R
    Pascal, G
    Castaing, D
    Azoulay, D
    Delvart, V
    Paule, B
    Levi, F
    Bismuth, H
    [J]. ANNALS OF SURGERY, 2004, 240 (06) : 1052 - 1064
  • [3] Adam R, 2001, ANN SURG ONCOL, V8, P347
  • [4] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545
  • [5] Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection
    Belghiti, J
    Hiramatsu, K
    Benoist, S
    Massault, PP
    Sauvanet, A
    Farges, O
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2000, 191 (01) : 38 - 46
  • [6] Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
    Bismuth, H
    Adam, R
    Levi, F
    Farabos, C
    Waechter, F
    Castaing, D
    Majno, P
    Engerran, L
    [J]. ANNALS OF SURGERY, 1996, 224 (04) : 509 - 520
  • [7] Liver resection for colorectal metastases
    Bramhall, SR
    Gur, U
    Coldham, C
    Gunson, BK
    Mayer, AD
    McMaster, P
    Candinas, D
    Buckels, JAC
    Mirza, DF
    [J]. ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2003, 85 (05) : 334 - 339
  • [8] The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer
    Canna, K
    McArdle, PA
    McMillan, DC
    McNicol, AM
    Smith, GW
    McKee, RF
    McArdle, CS
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (04) : 651 - 654
  • [9] Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastases
    Chalmers, C. R.
    Wilson, D. J.
    Ward, J.
    Robinson, P. J.
    Toogood, G. J.
    Hull, M. A.
    [J]. GUT, 2006, 55 (07) : 1058 - 1059
  • [10] Chen Li, 2004, Hepatobiliary Pancreat Dis Int, V3, P530